FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1954080 · Received January 10, 2011

Report

Report Number
2124215-2010-24213
Event Type
Injury
Date Received
January 10, 2011
Date of Event
December 15, 2010
Report Date
January 28, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A NEW RIGHT VENTRICULAR LEAD WAS SUCCESSFULLY IMPLANTED. TO DATE, THE EXPLANTED LEAD HAS NOT BEEN RECEIVED AT BOSTON SCIENTIFIC. UPON RECEIPT, THE LEAD WILL UNDERGO DETAILED LABORATORY ANALYSIS IN AN ATTEMPT TO CONFIRM AND DETERMINE THE ROOT CAUSE OF THIS EVENT.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. ANALYSIS REVEALED THAT THE INNER AND OUTER INSULATION OF THE LEAD WAS ABRADED THROUGH. THIS FINDING MAY HAVE CONTRIBUTED TO THE CLINICAL OBSERVATION. THE ABRASION COULD HAVE BEEN RUBBED BETWEEN THE INNER AND OUTER COILS. THE ABRASION WAS AT 31-32CM FROM THE TERMINAL PIN; POSSIBLY DUE TO LEAD-ON-LEAD CONTACT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR LEAD HAS SUDDENLY EXHIBITED DECREASED IMPEDANCES OF 100 OHMS, LOSS OF CAPTURE WITH NO PACING THRESHOLD, AND NOISE. NO PACING INHIBITION GREATER THAN 2 SECONDS ASYSTOLE WAS OBSERVED AS THE PATIENT HAD AN INTRINSIC RHYTHM. A REVISION PROCEDURE WAS PERFORMED; DURING THE PROCEDURE, THE PATIENT DEVELOPED A HEMOTHORAX WITH PERICARDIAL EFFUSION WHICH REQUIRED CARDIO-PULMONARY RESUSCITATION. THE LEAD WAS REMOVED AND REPLACED. THE PATIENT IS RECOVERING IN THE CRITICAL CARE UNIT. THE EXPLANTED LEAD WAS RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening